Los Angeles Capital Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Los Angeles Capital Management's LMAT Position: Q1 2026 in Review
Los Angeles Capital Management reduced its LeMaitre Vascular (LMAT) stake by 38% in Q1 2026, selling an estimated $311K and leaving 5,255 shares worth $574K. The position accounts for ﹤0.01% of the portfolio, ranked #828.
Los Angeles Capital Management first reported a position in LMAT in Q1 2020 and has held it in 19 quarters since. The position peaked at $3.19M in Q1 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Los Angeles Capital Management held 5,255 shares of LeMaitre Vascular worth $574K as of Q1 2026.
- Los Angeles Capital Management sold 3,264 LeMaitre Vascular shares in Q1 2026, an estimated $311K.
- LeMaitre Vascular made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #828 holding.
- Los Angeles Capital Management first reported a position in LeMaitre Vascular in Q1 2020 and has held it in 19 quarters since.
- Los Angeles Capital Management's LeMaitre Vascular position peaked at $3.19M in Q1 2025.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.